Massively parallel sequencing of urinary DNA – the dawn of non-invasive bladder cancer detection and surveillance?

Research output: Contribution to journalEditorialpeer-review

1 Citation (Scopus)
150 Downloads (Pure)

Abstract

The recent paper by Dudley et al. (1) entitled “Detection and surveillance of bladder cancer using urine tumor DNA” adds to the burgeoning evidence that massively-parallel sequencing of urinary DNA reliably detects tumour-associated mutations in urinary DNA. This approach promises to resolve the long overdue need for a sensitive and specific non-invasive test for bladder cancer. In this editorial we discuss the existing body of evidence and what the study by Dudley et al. contributes to this rapidly-evolving field of cancer research.
Original languageEnglish
Pages (from-to)S204-S207
Number of pages4
JournalTranslational Cancer Research
Volume8
Issue numberSuppl 2
Early online date4 Mar 2019
DOIs
Publication statusPublished - 31 Mar 2019

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Fingerprint

Dive into the research topics of 'Massively parallel sequencing of urinary DNA – the dawn of non-invasive bladder cancer detection and surveillance?'. Together they form a unique fingerprint.

Cite this